RESUMEN
This is the second article in a two-part series published in this journal, in which we examine the histopathological characteristics, as well as the differential diagnosis, of the main entities that present as cystic and pseudocystic structures in cutaneous biopsy. In this second article, we address ciliated cutaneous cysts, branchial cysts, Bartholin's cysts, omphalomesenteric cysts, thymic cysts, thyroglossal duct cysts, synovial cysts, and median raphe cysts, as well as mucocele, ganglion, and auricular and digital myxoid pseudocysts.
Asunto(s)
Glándulas Vestibulares Mayores , Quistes , Femenino , Humanos , Quistes/patología , Diagnóstico Diferencial , Glándulas Vestibulares Mayores/patologíaRESUMEN
Cystic structures represent one of the most common findings in dermatopathology. These encompass both cystic tumors and pseudocysts resulting from the accumulation of certain substances, such as mucin. In a two-part series (of which this is the first part), we have reviewed the principal types of cysts and pseudocysts that may be observed in cutaneous biopsies, examining their histopathological features and primary differential diagnoses. This first part encompasses infundibular cysts, eruptive dermoid cysts, pigmented follicular cysts, pilonidal cysts, tricholemmal cysts, milium cysts, hybrid cysts, bronchogenic cysts, as well as steatocystoma, hydrocystoma, and comedones.
Asunto(s)
Quiste Broncogénico , Quiste Epidérmico , Humanos , Biopsia , Diagnóstico DiferencialRESUMEN
A 45-year-old-man presented a slightly painful proptosis and diplopia for 7 months. He had been kept elsewhere on oral steroids without evidence of any clinical response over an 8-week period with suspected diagnosis of an inflammatory pseudotumor upon referral to our clinic. An intraoperative biopsy positive for primary liposarcoma was followed by debulking surgery. Exenteration and radiotherapy were performed after pathologic confirmation of this diagnosis. No recurrence has been observed after 2 years of follow-up. We underline the importance of an accurate an early diagnosis in the management of this tumor, delayed in this case because of therapy with steroids.
Asunto(s)
Liposarcoma/cirugía , Neoplasias Orbitales/cirugía , Biopsia , Terapia Combinada , Diagnóstico Diferencial , Humanos , Liposarcoma/diagnóstico , Liposarcoma/radioterapia , Masculino , Persona de Mediana Edad , Neoplasias Orbitales/diagnóstico , Neoplasias Orbitales/radioterapiaRESUMEN
BACKGROUND: Fungi of the genus Fusarium are primarily plant pathogens and saprobes that produce disseminated infections in immunologically deficient humans. After aspergillosis, disseminated fusariosis is the second most common cause of invasive infection by filamentous fungi in patients with hematologic malignancies or those undergoing transplants of hematopoietic progenitors. AIMS: Disseminated fusariosis (DF) is considered an extremely rare infection and has reached a stable incidence rate, but its high mortality rate and the lack of an optimal management protocol have raised increasing interest in this mycosis. METHODS: We present three cases of DF produced by Fusarium oxysporum species complex, Fusarium solani species complex and the highly unusual Fusarium dimerum in patients with advanced hematological malignancies diagnosed in our hospital between 2007 and 2011. The species level identification of the Fusarium isolates was established by sequencing their TEF1 gene. RESULTS: The isolates showed low susceptibility to most of the antifungal agents analyzed, except that observed for F. dimerum to amphotericin B (AmB) and terbinafine, and F. oxysporum species complex to AmB. Interestingly, the strain of F. solani species complex exhibited high MIC values for AmB and voriconazole, notwithstanding these drugs were used for treatment with good results. Other relevant aspects to be considered in the treatment of DF are surgically cleaning foci of infection, withdrawing presumably contaminated catheters and recovery from neutropenia. CONCLUSIONS: The prevention of infection in colonized patients, the maintenance of a high level of diagnostic suspicion for early diagnosis, and the combined, vigorous and prolonged use of L-AmB and voriconazole are essential to decrease the mortality rate of this devastating infection.
Asunto(s)
Fusariosis/complicaciones , Neoplasias Hematológicas/complicaciones , Adolescente , Adulto , Anfotericina B/uso terapéutico , Antifúngicos/uso terapéutico , Fusariosis/diagnóstico , Fusariosis/tratamiento farmacológico , Humanos , Masculino , Persona de Mediana Edad , Voriconazol/uso terapéuticoRESUMEN
BACKGROUND: Saprochaete capitata (formerly known as Geotrichum capitatum and Blastoschizomyces capitatus) is a ubiquitous fungus found in soil, water, air, plants and dairy products. It colonizes the skin, and bronchial and intestinal tract of healthy people producing serious opportunistic infections in patients with haematological malignancies, especially in those with acute leukaemia. Since 1960s its presence is being increasingly recognized in this group of patients. The clinical spectrum of S. capitata disseminated infections is very similar to that produced by Candida, being easily misinterpreted. The associated high mortality and low susceptibility to fluconazole and echinocandins of S. capitata require the acknowledgement of this emergent infection so that it can be properly treated. CASE REPORT: We report 5 new cases of S. capitata disseminated infection in patients with advanced haematological malignancies observed in the haematology unit between the years 2004 and 2010, and review the state-of-the-art for diagnosis and treatment of this infection. CONCLUSIONS: Based on our experience, the prophylactic use of or the empirical antifungal treatment with fluconazole and/or echinocandins would not be adequate for oncohaematological patients in those hospitals where S. capitata infection may be highly prevalent.
Asunto(s)
Antifúngicos/uso terapéutico , Infección Hospitalaria/microbiología , Dipodascus/aislamiento & purificación , Fungemia/microbiología , Leucemia/complicaciones , Infecciones Oportunistas/microbiología , Adulto , Anciano , Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos , Linfoma de Burkitt/complicaciones , Linfoma de Burkitt/tratamiento farmacológico , Infecciones Relacionadas con Catéteres/tratamiento farmacológico , Infecciones Relacionadas con Catéteres/microbiología , Infección Hospitalaria/tratamiento farmacológico , Dipodascus/efectos de los fármacos , Farmacorresistencia Fúngica , Quimioterapia Combinada , Resultado Fatal , Neutropenia Febril/inducido químicamente , Femenino , Fungemia/tratamiento farmacológico , Humanos , Huésped Inmunocomprometido , Leucemia/tratamiento farmacológico , Masculino , Persona de Mediana Edad , Infecciones Oportunistas/tratamiento farmacológicoRESUMEN
Background. Fungi of the genus Fusarium are primarily plant pathogens and saprobes that produce disseminated infections in immunologically deficient humans. After aspergillosis, disseminated fusariosis is the second most common cause of invasive infection by filamentous fungi in patients with hematologic malignancies or those undergoing transplants of hematopoietic progenitors. Aims. Disseminated fusariosis (DF) is considered an extremely rare infection and has reached a stable incidence rate, but its high mortality rate and the lack of an optimal management protocol have raised increasing interest in this mycosis. Methods. We present three cases of DF produced by Fusarium oxysporum species complex, Fusarium solani species complex and the highly unusual Fusarium dimerum in patients with advanced hematological malignancies diagnosed in our hospital between 2007 and 2011. The species level identification of the Fusarium isolates was established by sequencing their TEF1 gene. Results. The isolates showed low susceptibility to most of the antifungal agents analyzed, except that observed for F. dimerum to amphotericin B (AmB) and terbinafine, and F. oxysporum species complex to AmB. Interestingly, the strain of F. solani species complex exhibited high MIC values for AmB and voriconazole, notwithstanding these drugs were used for treatment with good results. Other relevant aspects to be considered in the treatment of DF are surgically cleaning foci of infection, withdrawing presumably contaminated catheters and recovery from neutropenia. Conclusions. The prevention of infection in colonized patients, the maintenance of a high level of diagnostic suspicion for early diagnosis, and the combined, vigorous and prolonged use of L-AmB and voriconazole are essential to decrease the mortality rate of this devastating infection (AU)
Antecedentes. Los hongos del género Fusarium son principalmente patógenos vegetales que producen infecciones diseminadas en personas con deficiencias inmunológicas. Tras la aspergilosis, la fusariosis diseminada es la segunda causa de infección invasora por hongos filamentosos en pacientes con enfermedades hematológicas malignas o en receptores de trasplantes de progenitores hematopoyéticos. Objetivos. La fusariosis diseminada es muy infrecuente y ha alcanzado una tasa de incidencia estable. Sin embargo, el interés por estas micosis se ha incrementado debido a su alta tasa de mortalidad y a la falta de un tratamiento óptimo. Métodos. Se presentan tres casos de fusariosis diseminada por Fusarium oxysporum species complex (SC), Fusarium solani SC y Fusarium dimerum en pacientes de nuestro hospital con enfermedades hematológicas avanzadas, diagnosticados entre 2007 y 2011. Los aislamientos de Fusarium se identificaron mediante secuenciación del gen TEF1. Resultados. La sensibilidad a los antifúngicos ensayados fue baja salvo a la anfotericina B (AmB) y la terbinafina en F. dimerum, y a la AmB en F. oxysporum SC. Aunque F. solani SC mostró valores altos de CMI para la AmB y el voriconazol, su uso para el tratamiento del paciente dio buenos resultados. Otros aspectos relevantes para el tratamiento de la fusariosis diseminada son la limpieza quirúrgica de los focos de infección, la retirada de catéteres presumiblemente contaminados y la recuperación de la neutropenia. Conclusiones. La prevención de la infección en pacientes colonizados, el mantenimiento de un alto grado de sospecha para un diagnóstico temprano y el uso combinado, vigoroso y prolongado de L-AmB y voriconazol son esenciales para disminuir la mortalidad de esta infección devastadora (AU)
Asunto(s)
Adolescente , Adulto , Humanos , Masculino , Persona de Mediana Edad , Fusariosis/complicaciones , Fusarium/patogenicidad , Neoplasias Hematológicas/complicaciones , Antifúngicos/uso terapéutico , Fungemia/complicaciones , Anfotericina B/uso terapéutico , Huésped Inmunocomprometido , Análisis de Secuencia de ADNRESUMEN
Background. Saprochaete capitata (formerly known as Geotrichum capitatum and Blastoschizomyces capitatus) is a ubiquitous fungus found in soil, water, air, plants and dairy products. It colonizes the skin, and bronchial and intestinal tract of healthy people producing serious opportunistic infections in patients with haematological malignancies, especially in those with acute leukaemia. Since 1960s its presence is being increasingly recognized in this group of patients. The clinical spectrum of S. capitata disseminated infections is very similar to that produced by Candida, being easily misinterpreted. The associated high mortality and low susceptibility to fluconazole and echinocandins of S. capitata require the acknowledgement of this emergent infection so that it can be properly treated. Case report. We report 5 new cases of S. capitata disseminated infection in patients with advanced haematological malignancies observed in the haematology unit between the years 2004 and 2010, and review the state-of-the-art for diagnosis and treatment of this infection. Conclusions. Based on our experience, the prophylactic use of or the empirical antifungal treatment with fluconazole and/or echinocandins would not be adequate for oncohaematological patients in those hospitals where S. capitata infection may be highly prevalent (AU)